COL4A4 gene study of a European population: description of new mutations causing autosomal dominant Alport syndrome
- PMID: 25755845
- PMCID: PMC4348702
COL4A4 gene study of a European population: description of new mutations causing autosomal dominant Alport syndrome
Abstract
Background: Autosomal forms of Alport syndrome represent 20% of all patients (15% recessive and 5% dominant). They are caused by mutations in the COL4A3 and COL4A4 genes, which encode a-3 and a-4 collagen IV chains of the glomerular basement membrane, cochlea and eye. Thin basement membrane nephropathy may affect up to 1% of the population. The pattern of inheritance in the 40% of cases is the same as autosomal dominant Alport syndrome: heterozygous mutations in these genes. The aim of this study is to detect new pathogenic mutations in the COL4A4 gene in the patients previously diagnosed with autosomal Alport syndrome and thin basement membrane nephropathy in our hospital.
Methods: We conducted a clinical and genetic study in eleven patients belonging to six unrelated families with aforementioned clinical symptoms and a negative study of COL4A3 gene. The molecular study was made by conformation of sensitive gel electrophoresis (CSGE) and direct sequencing of the fragments that show an altered electrophoretic migration pattern.
Results: We found two pathogenic mutations, not yet described: IVS3 + 1G > C is a replacement of Guanine to Cytosine in position +1 of intron 3, in the splicing region, which leads to a pathogenic mutation. c.4267C > T; p.P1423S is a missense mutation, also considered pathogenic. We also found seven new polymorphisms.
Conclusions: We describe two new pathogenic mutations, responsible for autosomal dominant Alport syndrome. The other families of the study were undiagnosed owing to problems in the method employed and the possibility of mutations in other genes, giving rise to other diseases with similar symptoms.
Keywords: Autosomal alport syndrome; COL4A4 gene; missense; spicing.
Figures



Similar articles
-
Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome.Kidney Med. 2019 Aug 20;1(6):391-396. doi: 10.1016/j.xkme.2019.06.007. eCollection 2019 Nov-Dec. Kidney Med. 2019. PMID: 32734219 Free PMC article.
-
COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.Kidney Int. 2001 Aug;60(2):480-3. doi: 10.1046/j.1523-1755.2001.060002480.x. Kidney Int. 2001. PMID: 11473630
-
COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.Kidney Int. 2002 Jun;61(6):1947-56. doi: 10.1046/j.1523-1755.2002.00379.x. Kidney Int. 2002. PMID: 12028435
-
Heterozygous Pathogenic COL4A3 and COL4A4 Variants (Autosomal Dominant Alport Syndrome) Are Common, and Not Typically Associated With End-Stage Kidney Failure, Hearing Loss, or Ocular Abnormalities.Kidney Int Rep. 2022 Jun 7;7(9):1933-1938. doi: 10.1016/j.ekir.2022.06.001. eCollection 2022 Sep. Kidney Int Rep. 2022. PMID: 36090501 Free PMC article. Review.
-
Alport syndrome and thin basement membrane nephropathy.Nephron Clin Pract. 2007;106(2):c82-8. doi: 10.1159/000101802. Epub 2007 Jun 6. Nephron Clin Pract. 2007. PMID: 17570934 Review.
Cited by
-
Clinical Features and Familial Mutations in an Autosomal-Inherited Alport Syndrome Patient With the Presentation of Nephrotic Syndrome.Front Pediatr. 2021 Nov 11;9:678633. doi: 10.3389/fped.2021.678633. eCollection 2021. Front Pediatr. 2021. PMID: 34858896 Free PMC article.
-
Clinical and pathohistological characteristics of Alport spectrum disorder caused by COL4A4 mutation c.193-2A>C: a case series.Croat Med J. 2021 Jun 30;62(3):204-214. doi: 10.3325/cmj.2021.62.204. Croat Med J. 2021. PMID: 34212557 Free PMC article.
-
Identification of genes associated with primary open-angle glaucoma by bioinformatics approach.Int Ophthalmol. 2018 Feb;38(1):19-28. doi: 10.1007/s10792-017-0704-2. Epub 2017 Sep 11. Int Ophthalmol. 2018. PMID: 28894971
-
Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family.J Genet. 2017 Jun;96(2):389-392. doi: 10.1007/s12041-017-0786-7. J Genet. 2017. PMID: 28674241
-
Autosomal recessive Alport syndrome caused by a novel COL4A4 splice site mutation: a case report.Croat Med J. 2019 Oct 31;60(5):458-462. doi: 10.3325/cmj.2019.60.458. Croat Med J. 2019. PMID: 31686460 Free PMC article.
References
-
- Tazón B, Ars E, Torra R. The Alport syndrome. Nefrologia. 2003;23(Suppl 1):29–39. - PubMed
-
- Tazón Vega B, Badenas C, Ars E, Lens X, Milà M, Darnell A, Torra R. Autosomal recessive Alport’s syndrome and benign familial hematuria are collagen type IV diseases. Am J Kidney Dis. 2003;42:952–9. - PubMed
-
- Buzza M, Dagher H, Wang YY, Wilson D, Babon JJ, Cotton RG, Savige J. Mutations in the COL4A4 gene in thin basement membrane disease. Kidney Int. 2003;63:447–53. - PubMed
-
- Marcocci E, Uliana V, Bruttini M, Artuso R, Silengo MC, Zerial M, Bergesio F, Amoroso A, Savoldi S, Pennesi M, Giachino D, Rombolà G, Fogazzi GB, Rosatelli C, Martinhago CD, Carmellini M, Mancini R, Di Costanzo G, Longo I, Renieri A, Mari F. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome. Nephrol Dial Transplant. 2009;24:1464–71. - PubMed